Item Type | Name |
Concept
|
Antihypertensive Agents
|
Academic Article
|
Hypertension.
|
Academic Article
|
Monitoring of sympathetic activity in man: physiology and pharmacology.
|
Academic Article
|
Treatment of hypertensive crisis.
|
Academic Article
|
Managing the patient with hard-to-control hypertension.
|
Academic Article
|
Pretreatment with enalaprilat blunts nicardipine-induced sympathetic activation in spontaneously hypertensive and Wistar-Kyoto rats.
|
Academic Article
|
Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.
|
Academic Article
|
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.
|
Academic Article
|
High blood pressure in women.
|
Academic Article
|
Contemporary management of refractory hypertension.
|
Academic Article
|
Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy.
|
Academic Article
|
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
|
Academic Article
|
Resistant or difficult-to-treat hypertension.
|
Academic Article
|
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
|
Academic Article
|
The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.
|
Academic Article
|
Is there an unrecognized epidemic of primary aldosteronism? Pro.
|
Academic Article
|
Aldosteronism and hypertension.
|
Academic Article
|
Aldosterone excess and resistance to 24-h blood pressure control.
|
Academic Article
|
Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.
|
Academic Article
|
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
|
Academic Article
|
2008 American Heart Association Statement on diagnosis, evaluation, and treatment of resistant hypertension: what should we remember in everyday practice?
|
Academic Article
|
Sleep apnea, aldosterone, and resistant hypertension.
|
Academic Article
|
Resistant hypertension and aldosteronism.
|
Academic Article
|
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
|
Academic Article
|
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
|
Academic Article
|
Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
|
Academic Article
|
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
|
Academic Article
|
Resistant hypertension and hyperaldosteronism.
|
Academic Article
|
Aldosterone and cardiovascular disease.
|
Academic Article
|
Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study.
|
Academic Article
|
Resistant hypertension: who and how to evaluate.
|
Academic Article
|
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
|
Academic Article
|
Use of single-pill combination therapy in the evolving paradigm of hypertension management.
|
Academic Article
|
Characterization and treatment of resistant hypertension.
|
Academic Article
|
Current options for the treatment of resistant hypertension.
|
Academic Article
|
Apparent resistant hypertension and medication adherence.
|
Academic Article
|
Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study.
|
Academic Article
|
Reduction of blood pressure in patients with treatment-resistant hypertension.
|
Academic Article
|
Treatment of resistant hypertension.
|
Academic Article
|
Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension.
|
Academic Article
|
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
|
Academic Article
|
Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
|
Academic Article
|
Treatment of resistant hypertension.
|
Academic Article
|
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
|
Academic Article
|
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
|
Academic Article
|
Refractory hypertension: definition, prevalence, and patient characteristics.
|
Academic Article
|
Relation of torsion and myocardial strains to LV ejection fraction in hypertension.
|
Academic Article
|
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Academic Article
|
Resistant hypertension: bad and getting worse.
|
Academic Article
|
Resistant hypertension, obstructive sleep apnoea and aldosterone.
|
Academic Article
|
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.
|
Academic Article
|
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.
|
Academic Article
|
First Brazilian position on resistant hypertension.
|
Academic Article
|
Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function.
|
Academic Article
|
Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
|
Academic Article
|
True resistant hypertension: definition and prevalence.
|
Academic Article
|
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
|
Academic Article
|
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
|
Academic Article
|
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.
|
Academic Article
|
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
|
Academic Article
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
|
Academic Article
|
Apparent and true resistant hypertension: why not the same?
|
Academic Article
|
Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.
|
Academic Article
|
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity.
|
Academic Article
|
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.
|
Academic Article
|
Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension?
|
Academic Article
|
Predictors of silent myocardial ischemia in resistant hypertensive patients.
|
Academic Article
|
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Academic Article
|
Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels.
|
Academic Article
|
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
|
Academic Article
|
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
|
Academic Article
|
Management of hypertension in CKD: beyond the guidelines.
|
Academic Article
|
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
|
Academic Article
|
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.
|
Academic Article
|
Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.
|
Academic Article
|
Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step Beyond Observed Risk.
|
Academic Article
|
Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
|
Academic Article
|
Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?
|
Academic Article
|
Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.
|
Academic Article
|
A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
|
Academic Article
|
Do We Need a New Definition of Hypertension After SPRINT?
|
Academic Article
|
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
|
Academic Article
|
Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension.
|
Academic Article
|
Refractory versus resistant hypertension.
|
Academic Article
|
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.
|
Academic Article
|
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
|
Academic Article
|
11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.
|
Academic Article
|
National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
|
Academic Article
|
Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.
|
Academic Article
|
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.
|
Academic Article
|
Resistant Hypertension: An Update of Experimental and Clinical Findings.
|
Academic Article
|
Antihypertensive Medications and Falls in the Elderly.
|
Academic Article
|
The New ACC/AHA Hypertension Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
|
Academic Article
|
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
|
Academic Article
|
Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes.
|
Academic Article
|
White-Coat Effect Is Uncommon in Patients With Refractory Hypertension.
|
Academic Article
|
True versus pseudoresistant hypertension.
|
Academic Article
|
Case of Refractory Hypertension Controlled After Aortic and Mitral Valve Replacement and Coronary Artery Bypass Grafting.
|
Academic Article
|
Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.
|
Academic Article
|
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
|
Academic Article
|
Resistant Hypertension: An Update.
|
Academic Article
|
Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.
|
Academic Article
|
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
|
Academic Article
|
Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
|
Academic Article
|
Prevalence of refractory hypertension in the United States from 1999 to 2014.
|
Academic Article
|
The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.
|
Academic Article
|
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.
|
Academic Article
|
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
|
Academic Article
|
Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
|
Academic Article
|
Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: a post-hoc intention-to-treat analysis of the HIPARCO randomized clinical trial.
|
Academic Article
|
Treatment of Resistant and Refractory Hypertension.
|
Academic Article
|
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study.
|
Academic Article
|
Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension.
|
Academic Article
|
Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
|
Academic Article
|
Case of Episodic and Positional Hypertension: Diagnosis and Treatment.
|
Academic Article
|
Obstructive sleep apnea is more severe in men but not women with refractory hypertension compared with controlled resistant hypertension.
|
Academic Article
|
Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
|
Academic Article
|
Uric Acid Is Not Associated With Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure Phenotypes.
|
Academic Article
|
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.
|
Academic Article
|
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.
|
Academic Article
|
An Update on Refractory Hypertension.
|
Academic Article
|
Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.
|